[Treatment's problem of osteoarticular infections in Madagascar]

S Ralandison1, R Randriamboavonjy, Soaniainamampionona

  • 1Service de rhumatologie-dermatologie, CHU JRB, Antananarivo, Madagascar. stephane.ralandison@yahoo.fr

Insights

This study models affordable osteoarticular infection treatment for developing countries. A combination of ceftriaxone, ciprofloxacin, and oxacillin proved effective for septic arthritis and osteitis.

Area of Science:

  • Infectious Diseases
  • Rheumatology
  • Pharmacology

Context:

  • Osteoarticular infections pose treatment challenges in developing countries due to limited diagnostic tools and low patient purchasing power.
  • International treatment guidelines often require resources unavailable in resource-limited settings.
  • This study addresses the need for cost-effective treatment strategies for septic arthritis and osteitis in adults.

Purpose:

  • To model an effective and affordable antibiotic treatment strategy for osteoarticular infections in adult patients in developing countries.
  • To adapt international recommendations to the specific economic and clinical realities of developing nations.
  • To evaluate the efficacy of a specific antibiotic regimen in treating septic arthritis and osteitis.

Summary:

  • A retrospective study analyzed 9 adult inpatients (7 septic arthritis, 2 osteitis) at Antananarivo University Hospital.
  • Staphylococcus aureus was identified in two osteitis cases; no pathogens were isolated in septic arthritis cases.
  • A regimen of intravenous ceftriaxone and ciprofloxacin, followed by oral oxacillin and ciprofloxacin, was effective for all patients.

Impact:

  • The proposed treatment strategy offers a viable, cost-effective approach to managing osteoarticular infections in resource-limited settings.
  • This model demonstrates successful adaptation of international guidelines to local constraints, improving patient outcomes.
  • The recommended antibiotic combination provides a practical solution for treating severe bone and joint infections where diagnostics are limited.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Rocky Mountain Spotted Fever01:26

Rocky Mountain Spotted Fever

Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...